These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18087102)

  • 1. Mycobacterium fortuitum keratitis.
    Sanghvi C
    Indian J Med Microbiol; 2007 Oct; 25(4):422-4. PubMed ID: 18087102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.
    Hu FR; Luh KT
    Ophthalmology; 1998 Feb; 105(2):269-72. PubMed ID: 9479286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment.
    Abshire R; Cockrum P; Crider J; Schlech B
    Clin Ther; 2004 Feb; 26(2):191-6. PubMed ID: 15038942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual clinical presentation of Mycobacterium fortuitum infection in an immunocompetent woman.
    Serra C; Loi G; Saddi B; Pautasso M; Manzin A
    J Clin Microbiol; 2007 May; 45(5):1663-5. PubMed ID: 17360837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of photodynamic therapy on rapidly growing nontuberculous mycobacteria keratitis.
    Shih MH; Huang FC
    Invest Ophthalmol Vis Sci; 2011 Jan; 52(1):223-9. PubMed ID: 20811055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extensive lamellar keratectomy for treatment of nontuberculous mycobacterial keratitis.
    Hu FR
    Am J Ophthalmol; 1995 Jul; 120(1):47-54. PubMed ID: 7611329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium fortuitum as a cause of peritoneal dialysis catheter port infection. A clinical case and a review of the literature.
    Martínez López AB; Álvarez Blanco O; Ruíz Serrano MJ; Morales San-José MD; Luque de Pablos A
    Nefrologia; 2015; 35(6):584-6. PubMed ID: 26565935
    [No Abstract]   [Full Text] [Related]  

  • 8. Mycobacterium szulgai keratitis.
    Frueh BE; Dubuis O; Imesch P; Böhnke M; Bodmer T
    Arch Ophthalmol; 2000 Aug; 118(8):1123-4. PubMed ID: 10922211
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-Facelift Infection Due to Mycobacterium Fortuitum: A Case Report.
    Chazan B; Shoufani A; Strauss M; Yanovskay A
    Isr Med Assoc J; 2018 Aug; 20(8):524-525. PubMed ID: 30084582
    [No Abstract]   [Full Text] [Related]  

  • 10. Atypical cutaneous mycobacteriosis caused by M. fortuitum acquired in domestic environment.
    Silva DLFD; Valandro LDS; Velho PENF; França AFEDC
    An Bras Dermatol; 2020; 95(3):390-391. PubMed ID: 32331920
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of amikacin in the treatment of primary cutaneous mycobacteriosis due to Mycobacterium fortuitum.
    Ena P; Zanetti S; Sechi LA; Fadda G; Leigheb G
    J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):66-7. PubMed ID: 10188156
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinicopathologic study of satellite lesions in nontuberculous mycobacterial keratitis.
    Hu FR; Huang WJ; Huang SF
    Jpn J Ophthalmol; 1998; 42(2):115-8. PubMed ID: 9587843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusual pathogen causing microbial keratitis.
    Saeed MU; Jafree AJ; DeCock R; Nash J
    Acta Ophthalmol Scand; 2004 Oct; 82(5):606-8. PubMed ID: 15453863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mycobacterium fortuitum infection associated with achalasia.
    Bouchentouf R
    Tunis Med; 2018 May; 96(5):311-313. PubMed ID: 30430507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endobronchial Lesions in an Immunocompromised Host: An Atypical Case for Mycobacterium fortuitum.
    Abia-Trujillo D; Kornafeld A; Fernandez-Bussy S
    J Bronchology Interv Pulmonol; 2020 Oct; 27(4):e65-e66. PubMed ID: 32960865
    [No Abstract]   [Full Text] [Related]  

  • 16. Non-tuberculous mycobacterial keratitis.
    Chu HS; Hu FR
    Clin Microbiol Infect; 2013 Mar; 19(3):221-6. PubMed ID: 23211011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutaneous non-tubercular mycobacterial infection in pregnancy and treatment consideration.
    Dabas G; Sharma K; Narang T; Sharma M; Chatterjee D; Dogra S
    Eur J Obstet Gynecol Reprod Biol; 2019 Jun; 237():215-216. PubMed ID: 31006504
    [No Abstract]   [Full Text] [Related]  

  • 18. Mycobacterium massiliense keratitis.
    Liu X; Zhao Y; Yang Y; Xu Y; Jiang Y; Dong F; Long Q
    Optom Vis Sci; 2012 Jun; 89(6):E944-7. PubMed ID: 22327797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of topical ciprofloxacin for treating Mycobacterium fortuitum and Mycobacterium chelonae keratitis in an animal model.
    Lin R; Holland GN; Helm CJ; Elias SJ; Berlin OG; Bruckner DA
    Am J Ophthalmol; 1994 May; 117(5):657-62. PubMed ID: 8172274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interface keratitis due to Mycobacterium fortuitum following laser in situ keratomileusis.
    Fogla R; Rao SK; Padmanabhan P
    Indian J Ophthalmol; 2003 Sep; 51(3):263-5. PubMed ID: 14601856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.